Hancock jaffe laboratories, inc. (HJLI)
Income statement / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17Jun'17
Revenues:
Total Revenues

31

61

103

186

186

0

0

0

0

0

Cost of revenues

-

-

-

-

-

-

-

-

0

0

Gross Profit

-

-

-

-

-

-

-

-

0

0

Selling, general and administrative expenses

4,911

5,205

5,153

6,536

6,482

0

0

0

0

0

Research and development expenses

2,206

1,711

1,459

1,311

1,238

0

0

0

0

0

Loss from Operations

-7,675

-7,175

-6,828

-7,980

-7,854

0

0

0

0

0

Other (Income) Expense:
Amortization of debt discount

-

-

-

-

6,562

0

0

0

0

0

Gain on extinguishment of convertible notes payable

-

-

-

-

1,481

0

0

0

0

0

Interest (income) expense, net

-49

-58

-46

79

298

0

0

0

-

-

Interest expense, net

-

-

-

-

-

-

-

-

0

0

Change in fair value of derivative liabilities

-

-

-

-

191

0

0

0

0

0

Total Other (Income) Expense

-49

-58

-59

1,888

5,187

0

0

0

0

0

Net Loss

-7,625

-7,116

-6,769

-9,868

-13,042

0

0

0

0

0

Deemed dividend to preferred stockholders

-

-

-

-

3,310

0

0

0

0

0

Net Loss Attributable to Common Stockholders

-7,625

-7,116

-6,769

-13,049

-16,352

0

0

0

0

0

Net Loss Per Basic and Diluted Common Share:

-0.12

-0.10

-0.13

-0.13

0.24

-0.13

-1.06

-0.80

-0.39

-0.22

Weighted Average Number of Common Shares Outstanding: Basic and Diluted

18,014

17,922

14,838

12,267

11,817

11,717

7,781

6,133

6,126

6,123

Royalty Income [Member]
Total Revenues

-

-

-

-

-

0

0

-

-

-

Contract Research - Related Party [Member]
Total Revenues

-

-

-

-

-

0

0

-

-

-